Clinical Trial

Neoadjuvant Radiotherapy and Surgery for High-Risk Localized Ewing Sarcoma

Name: Neoadjuvant Radiotherapy and Surgery for High-Risk Localized Ewing Sarcoma — clinical trial record (NCT07620431)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This is a single-center, single-arm, prospective observational study to evaluate the long-term local control rate, safety, and efficacy of preoperative neoadjuvant radiotherapy (36-45 Gy) followed by sequential radical surgery and postoperative chemotherapy in patients with high-risk, resectable localized Ewing sarcoma.

Trial Details

NCT Number	NCT07620431
Lead Sponsor	Peking University People's Hospital
Conditions	Ewing Sarcoma, Bone Neoplasms
Enrollment	55 participants
Start Date	2026-06-01
Primary Completion	2027-12-01 (estimated)
Study Completion	2027-12-01 (estimated)
Updated on ClinicalTrials.gov	2026-06-02